Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT ID: NCT00699868
Last Updated: 2012-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2008-03-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy
NCT02129465
Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients
NCT00467532
Biomarkers of Cytomegalovirus Fetal Infection and Disease
NCT03090841
The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
NCT01081379
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Infection to CMV
Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Sampling of blood
2
Group "control CMV"
Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Sampling of blood
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Sampling of blood
Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Sampling of blood
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
Exclusion Criteria
* pregnant or lactating women,
* adults under guardianship,
* immunosuppression at the entrance to resuscitation,
* AIDS
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Assistance Publique Hopitaux De Marseille
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Marie FOREL, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hôpitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital de Sainte Marguerite- Service de Réanimation Médicale
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Matta J, Baratin M, Chiche L, Forel JM, Cognet C, Thomas G, Farnarier C, Piperoglou C, Papazian L, Chaussabel D, Ugolini S, Vely F, Vivier E. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood. 2013 Jul 18;122(3):394-404. doi: 10.1182/blood-2013-01-481705. Epub 2013 May 17.
Forel JM, Chiche L, Thomas G, Mancini J, Farnarier C, Cognet C, Guervilly C, Daumas A, Vely F, Xeridat F, Vivier E, Papazian L. Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS One. 2012;7(12):e50446. doi: 10.1371/journal.pone.0050446. Epub 2012 Dec 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-A01197-46
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.